Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Instrumentation Laboratory upcoming IVD launches to include Synthesis critical care analyzer.

This article was originally published in The Gray Sheet

Executive Summary

INSTRUMENTATION LABORATORY IVD PRODUCT LINE EXTENSIONS in critical care, hemostasis and clinical chemistry in vitro diagnostics are slated for introduction in the next 12 months, the firm says in a prospectus for its recently completed initial public offering of 5.4 mil. American Depositary Shares ("The Gray Sheet" Nov. 11, p. 25). The new products are a "key element" of the Milan, Italy-based firm's strategy to build on core strengths and "capitalize on opportunities for growth and profitability," the firm states.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT007108

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel